Securing investment is paramount for biotechnology companies striving for robust growth. As the industry evolves, a deep knowledge of financial strategies becomes increasingly crucial. Venture capitalists often seek companies with a strong portfolio of success and compelling research. To obtain the necessary capital, biotech companies must present